Author:
Larsson Erik,Ljungberg Michael,Mårtensson Linda,Nilsson Rune,Tennvall Jan,Strand Sven-Erik,Jönsson Bo-Anders
Reference25 articles.
1. Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: Establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy;Mårtensson;Clin. Cancer Res.,2005
2. Correlation of red marrow radiation dosimetry with myelotoxicity: Empirical factors influencing the radiation-induced myelotoxicity of radiolabeled antibodies, fragments and peptides in pre-clinical and clinical settings;Behr;Cancer Biother. Radiopharm.,2002
3. Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: Radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen;Vallabhajosula;J. Nucl. Med.,2005
4. Prediction of myelotoxicity using semi-quantitative marrow image scores;Lim;J. Nucl. Med.,1997
5. Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources;Lim;J. Nucl. Med.,1997
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献